Response to the letter to the editor concerning "Development and internal validation of a clinical prediction model for 90-day clinically significant medication-related harm in adults initiating oral anticancer therapy: A multicenter prospective cohort study".

IF 1.3 4区医学 Q4 ONCOLOGY

Journal of Oncology Pharmacy Practice Pub Date : 2026-10-14 DOI:10.1177/10781552261498683

Vivek Jayan, Sankiya M, Sudhakar S, Hana Zaiba Z, Aiswarya Lily Ray, Rakesh M

引用次数: 0

查看原文本刊更多论文

回复给编辑关于“开始口服抗癌治疗的成人90天临床显著药物相关危害的临床预测模型的开发和内部验证：一项多中心前瞻性队列研究”的信。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Oncology Pharmacy Practice Medicine-Oncology

CiteScore

2.70

自引率

7.70%

发文量

276

期刊介绍： Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...